The decrease of SOD activity in diabetic nephropathy was widely known through previous experiments, and tempol treatment in diabetic nephropathy restored renal function and the activity of antioxidant enzymes, including SOD and GPx [42,145,146,147]. Here, SOD1 is linked to diabetic kidney disease.